ANNOUNCING CANNAMEDICAL® PHARMA AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON
Cannabis Europa is excited to announce Cannamedical® Pharma as a Bronze Partner for our London conference this June at the Southbank Centre.
Cannamedical® Pharma is a GDP-certified and fully licensed pharmaceutical wholesaler in accordance with the German Medicines Act (AMG) and licensed narcotics dealer in accordance with the German Narcotics Legislation. In addition, the company is permitted to import narcotic medicines into Germany and export to member states of the European Union (EU) and beyond.
Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe, dedicated to creating a platform for European leadership in the global cannabis industry. Leaders gather for thought-provoking panel discussions that aim to provide solutions to the most pressing issues in the European industry. Cannamedical® Pharma focuses on creating a stable supply of high-quality, regulated and compliant cannabis products for European patients.
Stable Supply for Patients
Cannabis Europa brings together European entrepreneurs and leading operators in the medical cannabis industry to discuss the future of the industry. On June 24th and 25th we will explore the evolution of clinical trials and the ways in which the pharmaceutical industry and the medical cannabis industry can collaborate to provide reliable cannabis-based medicines for European patients.
New European markets are coming online and educational frameworks are being developed regionally but despite growing interest and demand for medical cannabis, there is still a significant amount of work to be done to establish a stable supply of cannabis for patients. This has become a priority for European patients and operators.
Cannamedical Pharma GmbH is committed to creating long-term relationships with reliable suppliers, improve supply chain management and provide assistance to authorities. The company was founded in 2016 and has around 50 employees in Cologne. In addition, Cannamedical operates subsidiaries in Canada and the UK.
To date, Cannamedical has supported two international companies in their bid for EU-GMP certification and currently supports four more companies in their application. At this point in time Cannamedical® Pharma is the only independent company that has successfully imported medical cannabis from outside the EU to Germany.
“As independent leader of the young German cannabis industry, we at Cannamedical® are excited to be a part of this year’s Cannabis Europa. We are determined to improve the quality of patient’s lives around Europe. For that we work closely with partners on three continents and made it our mission to create new and innovative treatments with products of the highest quality to provide patients with the best possible care.” David Henn, CEO & founder of Cannamedical®.
Cannabis Europa London will discuss the most important trends and challenges in the evolving European market, offering a meeting space for both European entrepreneurs and experienced global operators. Join the conversation now and book your ticket.